Prof.Christopher Zeitz / Director of Cardiology / The Queen Elizabeth Hospital (Central Adelaide Local Health Network) He has more than 25 years' experience as an interventional cardiologist, and his special interests include acute coronary syndrome and coronary vasodynamic reactivity.
The number of patients presenting with cardiovascular or ischemic heart disease has drastically increased over the years, and with it, so has the demand for cardiac catheterization labs to perform complex procedures on high-risk individuals. For our team at The Queen Elizabeth Hospital (TQEH), the most significant challenges posed, are those by Australia’s aging population, an ever-increasing range of co-morbidities, and an overall rise in patient BMI.
To address these issues head-on, we chose to focus our strategic efforts on sourcing a solution that would enable our team to achieve optimal diagnostic imaging to treat a range of complex cardiac pathologies – particularly in the acute setting. Having previously invested $4 million in the re-development of our cardiac services, it was essential that this solution could quickly adapt and future-proof our clinical efficacy as the market evolves.
After much discussion, it was decided that the Alphenix Core + by Canon Medical was the ideal choice. We had already been using the Infinix-i for several years, but now it was time to invest in an upgrade that would successfully service this complex set of patient needs.
“We have also been able to reduce dose by up to 85% with built-in Spot ROI technology.”
Prof.Christopher Zeitz
Director of Cardiology
Dose Tracking System
Finally, advanced Dose Tracking System (DTS) software provides comprehensive awareness of the local dose being administered at the point of treatment, as well as instant feedback and repositioning options to lower the chance of radiation-induced injury.
The Queen Elizabeth Hospital Cardiac Team / TQEH is a 311-bed acute care teaching hospital that provides inpatient, outpatient, emergency, and mental health services to a population of more than 250,000 in Adelaide, South Australia. It is supported by 24 cardiologists, including 12 interventional specialists.
Overall, we feel that we have made the right choice with a flexible and versatile system that provides the required tools to conduct expert interventional procedures. With its increased image quality and low dose parameters, we are confident that we can deliver the very best care to our patients now and long into the future.//